These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25510665)

  • 1. EMSY promoted the growth and migration of ovarian cancer cells.
    Zhao X; Zhou Y; Nie M; Xian S; Chen H; Wen Y; Zhang L; Huang Y; Chen M; Wang S
    Tumour Biol; 2015 Apr; 36(4):3085-92. PubMed ID: 25510665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CIZ1 promoted the growth and migration of gallbladder cancer cells.
    Zhang D; Wang Y; Dai Y; Wang J; Suo T; Pan H; Liu H; Shen S; Liu H
    Tumour Biol; 2015 Apr; 36(4):2583-91. PubMed ID: 25427641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of EMSY gene in sporadic ovarian cancer.
    Altinisik J; Karateke A; Coksuer H; Ulutin T; Buyru N
    Mol Biol Rep; 2011 Jan; 38(1):359-63. PubMed ID: 20349280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases.
    Cousineau I; Belmaaza A
    Mol Genet Genomics; 2011 Apr; 285(4):325-40. PubMed ID: 21409565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.
    Hollis RL; Churchman M; Michie CO; Rye T; Knight L; McCavigan A; Perren T; Williams ARW; McCluggage WG; Kaplan RS; Jayson GC; Oza A; Harkin DP; Herrington CS; Kennedy R; Gourley C
    Cancer; 2019 Aug; 125(16):2772-2781. PubMed ID: 31154673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.
    Hughes-Davies L; Huntsman D; Ruas M; Fuks F; Bye J; Chin SF; Milner J; Brown LA; Hsu F; Gilks B; Nielsen T; Schulzer M; Chia S; Ragaz J; Cahn A; Linger L; Ozdag H; Cattaneo E; Jordanova ES; Schuuring E; Yu DS; Venkitaraman A; Ponder B; Doherty A; Aparicio S; Bentley D; Theillet C; Ponting CP; Caldas C; Kouzarides T
    Cell; 2003 Nov; 115(5):523-35. PubMed ID: 14651845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.
    Benusiglio PR; Lesueur F; Luccarini C; McIntosh J; Luben RN; Smith P; Dunning A; Easton DF; Ponder BA; Pharoah PD
    BMC Cancer; 2005 Jul; 5():81. PubMed ID: 16029503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of EMSY gene amplification in human cancers.
    Wilkerson PM; Dedes KJ; Wetterskog D; Mackay A; Lambros MB; Mansour M; Frankum J; Lord CJ; Natrajan R; Ashworth A; Reis-Filho JS
    J Pathol; 2011 Sep; 225(1):29-42. PubMed ID: 21735447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarifying the role of EMSY in DNA repair in ovarian cancer.
    Kondrashova O; Scott CL
    Cancer; 2019 Aug; 125(16):2720-2724. PubMed ID: 31154666
    [No Abstract]   [Full Text] [Related]  

  • 10. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
    Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D
    Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.
    Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C
    Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGIF1 promoted the growth and migration of cancer cells in nonsmall cell lung cancer.
    Xiang G; Yi Y; Weiwei H; Weiming W
    Tumour Biol; 2015 Dec; 36(12):9303-10. PubMed ID: 26104768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM37 promoted the growth and migration of the pancreatic cancer cells.
    Jiang J; Tian S; Yu C; Chen M; Sun C
    Tumour Biol; 2016 Feb; 37(2):2629-34. PubMed ID: 26395261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.
    Bane AL; Mulligan AM; Pinnaduwage D; O'Malley FP; Andrulis IL
    Breast Cancer Res Treat; 2011 Jun; 127(3):831-9. PubMed ID: 21327470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of EMSY, a novel BRCA2-link protein, is associated with lymph node metastasis and increased tumor size in breast carcinomas.
    Madjd Z; Akbari ME; Zarnani AH; Khayamzadeh M; Kalantari E; Mojtabavi N
    Asian Pac J Cancer Prev; 2014; 15(4):1783-9. PubMed ID: 24641409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY.
    Raouf A; Brown L; Vrcelj N; To K; Kwok W; Huntsman D; Eaves CJ
    J Natl Cancer Inst; 2005 Sep; 97(17):1302-6. PubMed ID: 16145051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
    Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
    Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKAP2 is upregulated in ovarian cancer, and promotes growth and migration of cancer cells.
    Li X; Wang C; Zhang G; Liang M; Zhang B
    Mol Med Rep; 2017 Oct; 16(4):5151-5156. PubMed ID: 28849175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
    Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
    BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis.
    Wang Z; Liu Y; Lu L; Yang L; Yin S; Wang Y; Qi Z; Meng J; Zang R; Yang G
    Oncotarget; 2015 Mar; 6(9):6670-83. PubMed ID: 25749384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.